Healthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain Outlook

Healthcare companies were among the worst performing stocks Wednesday, with biotechnology sector-specific ETFs taking the brunt of the hit, after FDA Commissioner Scott Gottlieb unexpectedly resigned, casting a cloud over policy changes ahead. On Wednesday, the Health Care Select Sector SPDR ETF...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.